Blaine Labs Recalls
9 recalls on record · March 30, 2022 to July 8, 2026 · Drugs
Recalls by year
22
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, l
Hazard: CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Mi
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Lab
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockpo
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Loc
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma
Hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
July 8, 2026DrugsFDA
Blaine Labs Inc recalls TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy ca
Hazard: CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
July 8, 2026DrugsFDA
Blaine Labs Inc recalls Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufact
Hazard: Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
March 30, 2022DrugsFDA
Blaine Labs Inc recalls REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 2
Hazard: Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.